21 January 2020 - Genprex today announced that the U.S FDA has granted fast track Designation for Genprex’s Oncoprex immunogene ...
16 January 2020 - Valrox would be first gene therapy approved in U.S. for inherited type of haemophilia. ...
14 January 2020 - Swiss drug maker Roche plans to price its oral spinal muscular atrophy drug risdiplam aggressively to challenge ...
13 January 2020 - PTC-AADC MAA submitted; BLA now expected to be submitted in 2Q 2020. ...
11 January 2020 - Helen Obando is the youngest person ever to get a gene therapy that scientists hope will cure ...
8 January 2020 - ARU-1801 is being developed as a potential one-time treatment for patients suffering from sickle cell disease and ...
23 December 2019 - First marketing application submission in U.S. for gene therapy directed at any type of haemophilia. ...
12 December 2019 - The U.S. FDA today granted accelerated approval to Vyondys 53 (golodirsen) injection to treat Duchenne muscular dystrophy ...
12 December 2019 - Vyondys 53 is Sarepta’s second RNA exon-skipping treatment for DMD approved in the U.S. ...
25 November 2019 - Filing submission includes 12-month data from pivotal FIREFISH and SUNFISH trials in a broad population of people ...
21 November 2019 - Givlaari’s net price will be $442,000 after discounts included. ...
20 November 2019 - Today, the U.S. FDA granted approval to Givlaari (givosiran) for the treatment of adult patients with acute ...
2 November 2019 - Novartis scientists learnt months ago about safety concerns surrounding its gene therapy Zolgensma but delayed telling the ...
5 November 2019 - A new targeted gene therapy shows the promise and pitfalls of medical advances. ...
22 October 2019 - mRNA-3927 is Moderna’s second rare disease program to receive fast track designation. ...